Currently, there is a lack of evidence to guide the use of glucose-lowering agents in people with DKD. In a recently published Cochrane Systematic Review on insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease, no conclusions could be made for the types, dosages, or modes of administration of insulin. Here, INS is linked to diabetes mellitus.